Stockscreener 앱 받기
21.61
0.62%
-0.135
전일 마감가:
$21.75
열려 있는:
$21.5
하루 거래량:
54,402
Relative Volume:
0.16
시가총액:
$376.79M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+7.09%
1개월 성능:
+38.35%
6개월 성능:
-49.77%
1년 성능:
+0.00%
1일 변동 폭
$20.80
$21.72
1주일 범위
$19.55
$21.88
52주 변동 폭
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
명칭
Tectonic Therapeutic Inc
전화
(339) 666-3320
주소
490 ARSENAL WAY, WATERTOWN
TECX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
21.54 | 376.79M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.82 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.20 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.76 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.18 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.08 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Mizuho | Outperform |
| 2024-11-20 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-06-24 | 개시 | TD Cowen | Buy |
| 2023-12-18 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-05 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-27 | 개시 | Needham | Buy |
| 2021-03-09 | 개시 | Barclays | Overweight |
| 2021-03-02 | 개시 | Stifel | Hold |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | 개시 | Mizuho | Buy |
| 2019-04-05 | 개시 | Janney | Buy |
| 2018-10-10 | 개시 | Guggenheim | Buy |
| 2018-10-02 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-17 | 개시 | H.C. Wainwright | Buy |
| 2018-07-16 | 개시 | Wedbush | Outperform |
| 2018-07-16 | 개시 | Wells Fargo | Outperform |
모두보기
Tectonic Therapeutic Inc 주식(TECX)의 최신 뉴스
Insider Stock Buying Reaches US$62.6m On Tectonic Therapeutic - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Shares Sold by Wells Fargo & Company MN - Defense World
Geode Capital Management LLC Grows Stock Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
How did Tectonic Therapeutic Inc (TECX) fare last session? - uspostnews.com
Tectonic Announces $185 Million Private Placement - The Globe and Mail
Tectonic Therapeutic: A Buy On Massive Opportunity Of TX45 In PH HFpEF - Seeking Alpha
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated by Analysts at Mizuho - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Increase in Short Interest - Defense World
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Target Price at $77.75 - Defense World
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Mizuho Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation - Nasdaq
Mizuho Initiates Tectonic Therapeutic at Outperform - marketscreener.com
Mizuho sets Tectonic stock Outperform with $51 target - Investing.com Australia
Mizuho sets Tectonic stock Outperform with $51 target By Investing.com - Investing.com India
Tectonic Therapeutic Inc (NASDAQ: TECX): Blank Check For Growth? - Stocksregister
Vanguard Group Inc. Has $16.67 Million Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic To Present Phase 1B Data For Tx45 At European Society Of Cardiology Heart Failure 2025 - marketscreener.com
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025 - GlobeNewswire
Major Breakthrough: New Phase 1b Heart Failure Drug Data Promises Key Insights at ESC 2025 - Stock Titan
Tectonic Therapeutic Insider Bought Shares Worth $2,299,015, According to a Recent SEC Filing - marketscreener.com
Raymond James Financial Inc. Takes Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Major Investment Alert: Insider Buys Big in Tectonic Therapeutic! - TipRanks
Tectonic Therapeutic director Timothy Springer acquires $2.3 million in shares - Investing.com
Commonwealth Equity Services LLC Takes $231,000 Position in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Thursday 4/10 Insider Buying Report: TECX, GMS - Nasdaq
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares By Investing.com - Investing.com South Africa
Tectonic therapeutic director Timothy Springer acquires $8.55 million in shares - Investing.com Canada
Director’s Bold Move: Massive Stock Sale Shakes Tectonic Therapeutic! - TipRanks
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock By Investing.com - Investing.com South Africa
Tectonic therapeutic director Terrance McGuire sells $8.55m in stock - Investing.com
Tectonic Therapeutic Reports Strong 2024 Financial Results - TipRanks
Charles Schwab Investment Management Inc. Invests $218,000 in Tectonic Therapeutic (NASDAQ:TECX) - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Receives Consensus Recommendation of “Buy” from Analysts - The AM Reporter
Tectonic Therapeutic (NASDAQ:TECX) Receives $77.75 Average Price Target from Brokerages - Defense World
Tectonic Therapeutic: Buy Rating Affirmed on Strong Financials and Promising Pipeline - TipRanks
Wells Fargo & Company Lowers Tectonic Therapeutic (NASDAQ:TECX) Price Target to $101.00 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Given New $101.00 Price Target at Wells Fargo & Company - Armenian Reporter
Tectonic Therapeutic Inc. (TECX) reports earnings - Quartz
Tectonic Therapeutic Announces Fourth Quarter And Full Year 2024 Financial Results And Recent Business Highlights - Marketscreener.com
Tectonic Therapeutic Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Tectonic Therapeutic, Inc. SEC 10-K Report - TradingView
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic's TX45 Trial Achieves 30% Disease Reduction, Extends Runway to 2028 - StockTitan
Tectonic Therapeutic Inc expected to post a loss of $1.39 a shareEarnings Preview - TradingView
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Tectonic Therapeutic (TECX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Is Tectonic Therapeutic, Inc. (TECX) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
Brokerages Set Tectonic Therapeutic (NASDAQ:TECX) Price Target at $80.50 - Defense World
Tectonic Therapeutic Inc (TECX) 재무 분석
Tectonic Therapeutic Inc (TECX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.03%
0.49%
자본화:
|
볼륨(24시간):